Septerna (SEPN) Revenue & Revenue Breakdown
Septerna Revenue Highlights
Latest Revenue (Y)
$1.07M
Latest Revenue (Q)
$219.00K
Septerna Revenue by Period
Septerna Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $1.07M | 611.92% |
| 2023-12-31 | $151.00K | 100.00% |
| 2022-12-31 | - | - |
Septerna generated $1.07M in revenue during NA 2024, up 611.92% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Septerna Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $219.00K | 3.30% |
| 2024-12-31 | $212.00K | 20.45% |
| 2024-09-30 | $176.00K | 49.15% |
| 2023-12-31 | $118.00K | 257.58% |
| 2023-09-30 | $33.00K | - |
Septerna generated $219.00K in revenue during Q1 2025, up 3.30% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Septerna Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| NKTR | Nektar Therapeutics | $98.43M | $10.46M |
| SPRY | ARS Pharmaceuticals | $89.15M | $15.72M |
| TNGX | Tango Therapeutics | $42.07M | $3.18M |
| RLAY | Relay Therapeutics | $10.01M | $7.68M |
| PRAX | Praxis Precision Medicines | $8.55M | - |
| ZBIO | Zenas BioPharma | $5.00M | $10.00M |
| PRME | Prime Medicine | $2.98M | $1.11M |
| UPB | Upstream Bio | $2.37M | $566.00K |
| SEPN | Septerna | $1.07M | $219.00K |
| PROK | ProKidney | $76.00K | $221.00K |
| BCAX | Bicara Therapeutics | - | - |